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Abstract
Adherence to antipsychotic medication has demonstrated significant impact in decreasing
symptom exacerbation among patients diagnosed with mental illness. Antipsychotic medications
have several benefits including the management of psychotic and mood disorders; however, they
could cause unwanted medication side effects with metabolic and cardiovascular risks. This issue
is one of the commonly linked side effects resulting in nonadherence among mentally ill patients.
The purpose of this project was to implement a psychoeducational intervention using the
SIMPLE program to address metabolic and cardiovascular risks associated with antipsychotic
medications among adult patients diagnosed with mental illness. A sample size of sixteen adult
patients completed this project over a four-week period. There was a significant increase in mean
healthy lifestyle change score on pre-HPLP II (M = 16.675, SD = ± 2.385) compared to post-test
score; HPLP II (M = 21.104, SD = ± 2.287). The findings of this project supports that
psychoeducation promotes healthy lifestyle changes among patients prescribed antipsychotic
medications.
Keywords: psychoeducation, mental illness, antipsychotic medication, metabolic risks
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Minimizing Antipsychotic Medication Side Effects in Adults Diagnosed with Mental Illness
through Psychoeducation: An Evidence Based Approach
In contemporary societies, despite the tremendous strides made in the diagnosis and
management of chronic mental health disorders such as schizophrenia and depression, a large
section of this vulnerable population are not adherent to their treatment regimen (Owusu-Ansah
et al., 2018). Most of the potential modifiable risk factors for non-adherence are patient-related
such as poor insight into having a mental illness, substance abuse, lack of support system, as well
as the patient’s personal decision to stop taking medications (Sarath, Lokesh, Pramod, & Pavan,
2014). Another notable reason for nonadherence among a significant margin of patients
diagnosed with mental illness is the metabolic and cardiovascular side effects of antipsychotic
medications (Green, Janoff, Yarborough & Yarborough, 2014). Although multiple
pharmacological interventions are available in managing symptoms, antipsychotic medications
have proven to be very effective and is classified a cornerstone in managing the symptoms of
psychoses, depression, and mood disorder (Annamalai, Kosir & Tek, 2017). Despite the
immense benefits of antipsychotic medications in improving patient outcomes, antipsychoticinduced weight gain often ensues leading to cardiovascular and metabolic syndrome.
Background and Significance
In the United States (US) alone, nicotine dependence, substance use disorder, and obesity
resulted in soaring healthcare costs as well as decreased life expectancy by 10-25 years among
people diagnosed with psychotic disorders (Erickson et al., 2017). The American Hospital
Association (AHA), noted that health disparities among vulnerable populations continue to result
in poorer health outcomes and increased cost across the health system (AHA, 2019). The
healthcare costs were estimated to be $11.5 billion in 2013 (Erickson et al., 2017) with a
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projected spending of $280.5 billion by 2020 on behavioral health treatments alone (AHA,
2019).
The issue of antipsychotic induced weight gain transcends geographic boundaries thus
suggesting a diagnosis of schizophrenia as an independent risk factor for diabetes among this
patient population even in rural areas of sub-Saharan Africa (Owusu-Ansah et al., 2018). Mental
illness frequently causes alteration in mood and thought process leading to poor and impulsive
dietary choices and habits (Annamalai, Kosir & Tek, 2017). Many factors are reported to
contribute to metabolic and cardiovascular side effects among patients diagnosed with
schizophrenia, psychosis, or schizoaffective disorder who are prescribed antipsychotic
medications such as sedentary lifestyle, poor dietary habits and genetic susceptibility
(Dayabandra et al., 2017). Coupled with weight gain, antipsychotics medication can cause
elevated lipid levels and contribute to metabolic syndrome (Dayabandra et al., 2017). Metabolic
syndrome is a combination of abdominal obesity, high blood pressure, elevated triglycerides and
hyperglycemia (Penninx & Lange, 2018).
Patients diagnosed with schizophrenia have double the risk of developing metabolic
syndrome than people in the general population (Owusu-Ansah et al., 2018). Penninx and Lange
(2018) added that second-generation antipsychotics particularly have been linked to excessive
weight gain and risk of developing metabolic syndrome resulting in increased morality among
mentally ill patients. National Institute for Health and Clinical Excellence (NICE) noted that
increased metabolic and cardiovascular side effects are sometimes not a result of antipsychotic
medication alone but also the result of a diet which is low in fruits and vegetables as well as a
life with little to no physical activity (NICE, 2014). Psychoeducation empowers patients with
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information and in recent times has developed as an aspect of treatment of schizophrenia with
the goal of improving overall patient outcome (NICE, 2014).
Evidence-Based Intervention
Psychoeducation is a form of patient education/teaching which can be delivered in
multiple formats such as in print or verbally (Bäuml et al., 2016). Unlike other forms of patient
education offered to patients in print or verbal form, psychoeducation is an evidence-based form
of patient-centered care where patients and their families are offered attainable and practical
options towards improving overall wellbeing. The most important tenet of psychoeducation is to
ensure the manner in which this information is provided is well understood by the intended
audience. Bäuml et al. (2016) explained that psychoeducation often improves adherence and
motivates patients to strive for optimal wellbeing. The studies discussed in this project report
utilized psychoeducation as an evidence base practice (EBP) intervention with a patient-centered
care focus. By selecting psychoeducation as an intervention, patients prescribed antipsychotic
medications have the opportunity to understand and implement healthy lifestyle changes with the
aim of managing antipsychotic medication-induced metabolic side effects.
Purpose Statement
The purpose of this EBP change project was to implement a psychoeducational
intervention to address the problem of metabolic and cardiovascular risks associated with
antipsychotic medications among adult patients diagnosed with mental illness. The goal of the
project was to analyze the impact of group psychoeducational intervention on physical activity
level and fruit/vegetable intake as well as evaluate the effectiveness of psychoeducation on
healthy lifestyle changes among adult patients diagnosed with mental illness and prescribed
antipsychotic medications.
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Theoretical Framework
The theoretical framework which guided the implementation of this evidence-based
project (EBP) was Kurt Lewin’s Change theory which was introduced in the 1940s (Lewin,
1999; McEwen & Wills, 2014). This theory provided the foundation for effective
implementation of change by an individual or an entire group of people (McEwen & Wills,
2014). In order for an individual with a new or currently existing diagnosis of mental illness to
adhere to lifestyle changes through psychoeducation which has the potential to improve
outcome, that person would need to go through a transformational change. This change process
goes beyond the superficial alterations which are easily noticeable to address the mental and
emotional need to attain wellness.
Lewin’s Change theory is guided by three core concepts; driving forces, restraining
forces and equilibrium (Lewin, 1999). Lewin explained that driving force assists/accelerates
movement into the desired direction while the restraining force acts as an obstacle or stumbling
block to the new change process. This usually causes tension and imbalance however when a
state of equilibrium is reached both driving and restraining forces are equal resulting in no
change. McEwen and Wills (2014) added that it is essential for opposing/restraining forces to be
identified and eventually minimized so that the desired effect of change is achieved. Thus a
patient’s desire to attain optimal wellness acts as the driving force for medication/treatment
adherence while the restraining force of antipsychotic-induced weight gain/obesity pulls the
patient away from absolute compliance. Adapting the tenets of Lewin’s Change theory through
psychoeducation, patients were provided with the necessary tools needed to maneuver and
master the art of adherence to prescribed antipsychotic medication regimen while managing the
metabolic and cardiovascular medication side effects in a healthy manner.
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Lewin utilized three major stages of change; (unfreezing, moving, and refreezing) to
explain the complex processes an individual has to go through for lasting change to occur
(Lewin, 1999). The first stage of change, unfreezing, helps the patient understand the need for
change (White, 2014). The unfreezing stage is an important phase in the change process
especially as it has the tendency to decrease resistance to change if the patient affected by this
change is adequately educated about the need for change. During this phase, patients prescribed
antipsychotic medications were educated on the positive impact of adherence to antipsychotic
medication regimen as prescribed. A candid overview of the potential metabolic and
cardiovascular side effects of antipsychotic medications were discussed with patients. Patient’s
current dietary habits as well as physical activity level were assessed. Effective communication
was a necessity during this stage so that the patient who was affected by this change understood
the rationale behind its initiation. After creating an awareness of the need for change during the
unfreezing stage, White (2014) explained that the second stage, the moving stage, focuses on
strengthening the environment in order for change to occur. This stage introduced or reinforced
healthy lifestyle options which guided patients prescribed antipsychotic medications. The final
stage of Lewin’s change theory, the refreezing stage, became an opportunity to revisit results of
the lifestyle change, discuss challenges encountered or still facing, areas requiring alterations as
well as planning for the way forward (Manchester et al, 2014).
Lewin and Gold (1999) added that although any planned social change will have to
consider multiple factors there is still the need to ensure that reinforcement of the new patterns
are formally/informally instituted so that patients can conveniently reference in time of need.
Diligently educating patients prescribed antipsychotic medications about the need for healthier
lifestyle options through psychoeducation has the potential not only to move communities and
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the nation closer towards wellness but could lead towards preserving lives and improving overall
patient outcomes.
Literature Review
A literature search was conducted for this EBP project primarily through CINAHL,
PubMed, Medline, and Cochrane Collaboration. The keywords used during the initial search
included: metabolic side effects, antipsychotic-induced weight gain, and antipsychotics which
yielded less than four relevant systematic review articles and five randomized controlled trials
(RCTs). Other key words such as psychoeducation, lifestyle changes, obesity, diet, and atypical
antipsychotics were included in the search criteria. The five studies chosen were all RCTs
published within the past five years with similar underlying theme. The studies utilized
psychoeducation and lifestyle changes as an intervention to manage/counteract the metabolic and
cardiovascular side effects of antipsychotic medications.
Bersani et al. (2017) evaluated the clinical effectiveness of an educational intervention
targeting lifestyle habits in patients with mood and psychotic disorders. This RCT utilized a
double-blinded study design and adopted a theoretical framework based on a heuristic approach.
A sample size N=32 adults ages 18-65 were recruited at the day hospital of the psychiatric
department at University Hospital in Rome, Italy. Inclusion criteria for these participants were a
diagnosis of major depressive disorder, schizophrenia, and bipolar disorder. The intervention
group’s sample size n=16 received specialized educational sessions on healthy lifestyle changes
on diet, physical activity, and overall wellness while the control group’s sample size n=16
received non-specific psychoeducation on medication management or discussed patient’s clinical
outcomes (Bersani et al., 2017). The variables in this study included psychoeducation, lifestyle
habits, cardio-metabolic disturbances and individuals with psychiatric disorder. Three
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measurement tools used in this study were the Pittsburgh Sleep Quality Index (PSQI),
International Physical Activity Questionnaire (IPAQ), and Brief Psychiatric Rating Scale
(BPRS). The PSQI is a group of 19-self-rated questions grouped into seven clinically derived
domains of sleep difficulties and each of the seven domains is equally rated on a Likert scale of
0-3 to generate a global score of 0–21 where global PSQI score > 5 is indicative of poor sleep
quality. The IPAQ is a self-report measure rating the number of minutes spent exercising per day
in the previous week, and the intensity level of the exercise while the BPRS is an extensivelyvalidated clinician-rated scale using a 7-point Likert scale. Analysis of the intervention group
showed a significant positive change from baseline while scores of subjects in the control group
did not change significantly over time. Level of significance and confidence interval (CI) were
not stated. Findings for the study deduced decrease cardio metabolic disturbances related to
psychoeducation. This study reinforced that psychoeducation decreased a patient’s risk of other
cardiovascular diseases through lifestyle changes which led to improvement in overall health
status (Bersani et al., 2017).
Curtis et al. (2016) studied the effectiveness of a lifestyle and life skills intervention
delivered within four weeks of antipsychotic medication initiation in attenuating weight gain in
youth aged 14–25 years with first-episode psychosis. A motivational framework was used in this
RCT with prospective-controlled design. Young people ages 14-25 (N=28) were randomly
selected from two community-based first-episode psychosis (FEP) services with treatment with
antipsychotic medication for less than four weeks prior to baseline assessment. The intervention
group’s sample size n=16 while the comparison group’s sample size n=12. The intervention
group received health coaching, dietetic support and supervised exercise prescription. The
control group received standard care which involved individual mental health case management
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with medical assessment of prescribed antipsychotic medication following standard clinical
guidelines. Some of the dependent and independent variables included individualized lifestyle
and life skill, and psychoeducation. Overall, subjects in the intervention group reported lower
weight gain of 1.8kg compared to subjects in the control group who reported weight gain of
7.8kg. The study reported a moderate effect size with 95% CI. The outcome of the study
portrayed decreased weight gain related to psychoeducation on individualized lifestyle and life
skill. The authors reinforced that implementing effective lifestyle and life skills interventions
from the initiation of treatment as part of routine care has the potential to result in improved
patient outcome.
Erickson et al. (2017) studied the behavioral interventions for veterans with mental
illness and antipsychotic medication-associated obesity. This RCT utilized a sample size of 121
adults mainly male veterans with some non-veteran women ages 18-70. Research activities took
place in research offices near mental health clinics at the Greater Los Angeles Veterans
Administration (VA) and VA Long Beach Healthcare Systems and the participants had to have a
diagnosis of mental illness per DSM-IV, antipsychotic drug treatment, Body mass index (BMI) >
25, or weight > 7% on antipsychotic drugs. The major variables in this study were
psychoeducation, behavioral intervention, and lifestyle balance. One of the measurement tools
used was Self-Appraisal of Illness Questionnaire (SAIQ) which is a self-report instrument
designed to assess attitude towards mental illness among people receiving psychiatric
treatment. All clinical scores decreased over time; SAIQ showed a significant association with
treatment effect on weight change with higher scores associated with larger weight loss. The
study had a small effect size with 80% CI and reported decreased cardiovascular and metabolic
disturbances related to behavioral interventions on antipsychotic medication-associated obesity.
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Overall patient outcome would improve through routine education (oral/verbal and in
written/printed literature) on the benefits of healthy lifestyle choices while taking antipsychotic
medication.
Green, Janoff, Yarborough and Yarborough (2014) tested the acceptability/feasibility of
the PREMIER/DASH Diet intervention among people taking antipsychotic medications as well
as tested the hypothesis that the intervention was more effective than usual care in reducing
weight. This RCT utilized motivational and behavioral change theories as its conceptual
framework. A sample size of 121 adults older than the age of 21 were recruited from a large, notfor-profit, integrated health plan in the US. The BMI range for participants was 24 - 44.9 and had
to be taking at least one antipsychotic medication at any consistent dose for a minimum of
30 days. The major variables in the study were lifestyle changes and psychoeducation with
intervention and control participants completing study questionnaires at baseline and posttreatment. The measurement tools used in this study were Eating Habits Confidence Survey
(EHSC), Exercise Confidence Questionnaire (ECQ), Social Support for Diet and Exercise
Behaviors (SSDEB), and Wisconsin Quality of Life -Medication Adherence Items (W-QLI). The
mean weight in the intervention group declined from 213.3 to 206.6 pounds, a mean reduction of
6.7 pounds (SD = 6.0). Level of significance and confidence interval (CI) were not stated.
Although this study used a small sample size, the study was of a pilot nature, and the participants
in the study were insured population and it would be premature to generalize the results to other
populations or settings, this RCT yielded similar findings in a study that occurred within an 18month timeframe which deduced that lifestyle and diet changed produced positive results in
patients prescribed antipsychotic medications.

MINIMIZING ANTIPSYCHOTIC SIDE EFFECT

15

Kreyenbuhl et al. (2017) conducted a RCT of a computerized, patient-centered
intervention aimed at educating veterans with serious mental illness about the metabolic side
effects of antipsychotics and encouraging them to advocate for receipt of guidelinerecommended side effect monitoring. The study used the patient-centered care framework with a
sample size of 240 veterans ages 18-70 at two Veterans Affairs outpatient mental health clinics
in the Mid-Atlantic region of the Unites States. In addition to the psychiatric diagnoses of
participants, veterans with a diagnosis of posttraumatic stress disorder (PTSD) were included in
the study as well as those prescribed one or more oral or injectable second generation
antipsychotic. The independent and dependent variables in this study were educational program
and lifestyle change. Responses were rated on a 5-point scale (0–4), with higher scores
representing greater symptom severity. Psychiatric symptom severity over the past week was
measured by the average score of the 24-item using Behavior and Symptom Identification Scale
(BASIS-24). Level of significance and confidence interval (CI) were not stated. The study noted
increased screening request from veterans for antipsychotic medication metabolic side effects
related to psychotherapy. Findings from the study supported the fact that individuals with serious
mental illness are interested in obtaining personalized information about their cardio-metabolic
status.
Synthesis of the Literature
Although five RCTs were reviewed with a wide range of similarities in their proposed
EBP intervention, they still possessed marked differences which were unique to each study.
Erickson et al (2017); Green et al. (2014) and Kreyenbuhl et al. (2017) randomly selected large
sample sizes between 121 and 240 participants ensuring generalization of their findings while
Curtis et al. (2016) and Bersani et al. (2017) had smaller sample sizes of 28-32 participants.
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Participants in all the studies were classified as adults between the ages of 18- 65/70 years except
for the study by Curtis et al. (2016) which sampled youth between the ages of 14-25 especially
since the focus of the study was on the youth population with FEP. The inclusion criteria of all
the studies stressed on an underlying diagnosis of mental illness with diagnoses of schizophrenia,
bipolar disorder, depression, and schizoaffective disorder however Kreyenbuhl et al. (2017)
added an additional diagnosis of PTSD. Although an underlying inclusion criteria for
participants in all the studies was receiving a prescription of antipsychotic medications and did
not specify but assumed an oral form of antipsychotic, Kreyenbuhl et al. (2017) was the only
study which specified that the antipsychotic medication had to be second-generation
antipsychotic which could be administered orally or through a long-acting injectable. Kreyenbuhl
et al. (2017) further narrowed down participants for their study with the aimed at ensuring that
study findings could be adapted on a broad scale in that second-generation or atypical
antipsychotics have more notoriety for causing metabolic/cardiovascular side effects compared
to typical antipsychotics which produce more extrapyramidal symptoms (EPS).
All five studies used for this literature review adopted the same EBP intervention which
stressed on the effect of psychoeducation on lifestyle changes among participants to decease
metabolic and cardiovascular side effects of antipsychotic medications. Through
psychoeducation on lifestyle changes, Bersani et al. (2017), Curtis et al. (2016), Green et al.
(2014) and Erickson et al. (2017) reported participants experienced improved sleep habit,
decreased weight/BMI, as well as increased physical activity/exercise however Kreyenbuhl et al.
(2017) did not utilize direct psychoeducation on lifestyle changes. Participants in the study by
Kreyenbuhl et al. (2017) were encouraged to request frequent laboratory screening for fasting
blood glucose and lipid panel in order to detect any changes in metabolic function. Another
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deviation of this study from all the other studies was that unlike the other four studies which
reported decreased cardiovascular and metabolic risks related to psychoeducation, Kreyenbuhl et
al. (2017) reported increased weight gain and metabolic risks in spite of frequent request for
laboratory screenings. Increased knowledge on healthy lifestyle choices was however noted in all
participants of the various studies.
Agency Description
Setting
The project implementation occurred in an outpatient behavioral health clinic in Las
Vegas, Nevada in spring 2020. The clinic provides care to a large number of clients with diverse
mental illness. The setting for this EBP project was a mental health clinic located in the Las
Vegas Valley. The clinic serves clients over the age of six years to geriatric population. The
common diagnoses managed at the clinic include bipolar disorder, depression, schizophrenia,
substance abuse, posttraumatic stress disorder, attention deficit hyperactive disorder and anxiety
disorder.
All clients served at the clinic have some form of private, state or federal-funded health
insurance while others are private pay clients. Some of the clients are homeless residing at
Catholic Charities or the Salvation Army who have health insurance coverage. The clinic is
conveniently located on the public transportation route with primary care outpatient clinics as
well as other healthcare facilities within close proximity. The setting was selected for
implementation of the project because of patients’ subjective reports and objective assessment of
antipsychotic induced medication side effects.
Target population
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Participants in this EBP change project were English-speaking adult patients over the
age of 18 diagnosed with mental illness and prescribed at least one antipsychotic medication.
Participants were welcomed from all ethnic backgrounds with no gender or religious preference.
Congruence of project to agency’s mission, goals, and strategic plan
Metabolic and cardiovascular risks associated with antipsychotic medication raises
concern among patients and healthcare providers. Melnyk and Fineout-Overholt (2015)
highlighted that internal evidence such as patient’s clinical status/circumstances, patient’s
preferences, and outcomes of quality improvement projects should be considered during clinical
decision making. For this project, in addition to patients’ subjective reports of weight gain and
exacerbation of underlying disease processes related to prescribed antipsychotic medication,
patient’s current dietary habits, as well as physical activity level were analyzed prior to delivery
of psychoeducational intervention. This internally generated data was compared with national
and global statistics of the problem of antipsychotic induced metabolic/cardiovascular risks and
its impact on society as a whole.
Stakeholders
The interprofessional team at the practice change site included psychiatrists, doctoral
prepared nurse practitioners, medical assistants, an office manager, information technology (IT)
personnel as well as accounting/billing department. Team members participated in this project
according to their scope of practice and job description. The psychiatrists and other nurse
practitioners referred interested patients prescribed antipsychotic medications to the Principal
Investigator (PI) who was responsible for providing psychoeducation. Scheduling of participants
for this project was the responsibility of the medical assistants. The preceptor for this project
served as a resource for the PI while Information Technology (IT) personnel assisted in

MINIMIZING ANTIPSYCHOTIC SIDE EFFECT

19

retrieving a list of past and current antipsychotic medication record from the electronic medical
records (EMR) as needed. Project participants constituted an important group of this project’s
stakeholders whose understanding and implementation of the psychoeducational intervention
was evaluated at the end of the entire project.
Project Design
This study utilized a pretest-posttest design. A weekly log tracking daily fruit and
vegetable intake as well as minutes of physical activity was collected at the start of this
educational intervention and throughout the four-week session. In week one of the group
sessions, data collected from HPLP II acted as baseline assessment. At the end of the 4-week
psychoeducational session, HPLP II was collected again to analyze whether participants gained
or adapted healthy lifestyle changes based on psychoeducation received. Data was collected by
the PI who was solely responsible for providing psychoeducation to participants during the
project implementation phase. The project utilized mixed data collection methods which
included questionnaire and anthropometric data. Data from the HPLP II was collected from
participants through a questionnaire while the data collection form was used by participants on
the first and last day of the psychoeducation session.
Methods
Evidence-Based Intervention: SIMPLE Program
The psychoeducational intervention which was used for this evidence-base practice
(EBP) project is the Simplified Intervention to Modify Physical activity, Lifestyle, and Eating
behavior (SIMPLE). SIMPLE is originally a 16-week lifestyle program focused on physical
activity and nutritional education which provided weight loss support as well as teaching on
healthy eating habits (Jean-Baptiste et al., 2007). This intervention was tailored within a four-
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week timeframe for participants to achieve maximum benefit. The program author provided
permission for changes to be made to the length of the program. The educational program is
independent of prior educational level, socioeconomic status as well as baseline cognition and
trains patients diagnosed with mental illness and prescribed antipsychotic medication how to
read food labels, prepare meals and practice portion control manage the metabolic medication
side effects (Jean-Baptiste et al, 2007). Written permission to use this educational tool was
sought and approved by Dr. Cent Tek with the stipulation to provide due reference to this
project. A resource manual describing this intervention as well as handouts for participants were
available for free downloads from the internet at no cost.
Implementation Framework
The selected model for the EBP project was the Model for Evidence-Based Practice. The
Model for Evidence Based Practice, a revised version of the model by Rosswurm and Larrabee
integrated the principles of quality improvement, utilization of team work tools and evidencebased translation to promote practice change (Larrabee, 2009). This EBP change model was
preferred because offered an in-depth, robust six-step process that guided practice change project
implementation. This model assessed the need for planned change within the practice site,
located the best evidence, critically analyzed the evidence, designed a practice change,
implemented and evaluated change in practice as well as integrated and maintained change in
practice (Larrabee, 2009). The project was categorized into four main stages which included
development and analysis of the intervention, an assessment of the practice site, implementation
of the psychoeducational intervention and evaluation of the effectiveness of the intervention.
Procedures
IRB Submission Process
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An expedited review application for Internal Review Board (IRB) approval was obtained
from Eastern Kentucky University (EKU) before the beginning of this project. After receiving
approval from EKU’s IRB, patients were recruited by referral from other prescribers at the
clinical site as well as through an open invitation process.
Recruitment
Following IRB approval of the project, participants were recruited for this project
through a cover letter offered to patients upon clinic check-in. Adult patients who were Englishspeaking and prescribed antipsychotic medications were provided with a cover letter as they
waited in the lobby for their scheduled appointment. The cover letter included an overview of the
project and patients were directed to the front desk who were interested in the study or met
criteria. A meeting with the PI was scheduled to discuss details of this project.
Measures and Instruments
Health-Promoting Lifestyle Profile II (HPLP II). The instrument which was used to
measure the effectiveness of SIMPLE as an effective psychoeducational tool among project
participants was the Health-Promoting Lifestyle Profile II (HPLP II). HPLP II was originally
designed by Walker, Sechrist, and Pender in 1987 and later revised in subsequent years. This
measurement tool is a 52-item utilizing a four-point response scale to assess the frequency of
self-reported health-promoting behaviors (Walker et al., 1987). The 52-items in this tool are
grouped into six subscales in the domain of stress management, interpersonal relations, physical
activity, nutrition, health responsibility and spiritual growth (Walker et al., 1987).
The four-point response scale which can be self-administered is itemized as; never,
sometimes, often, and routinely and is tallied by calculating the mean of all 52 items (Walker &
Hill-Polerecky, 2011). Walker and Hill-Polerecky (2011) added that in order to retain the metric
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of item responses and ensure meaningful comparison scores across subscales, the use of means
rather than the total of scale items is preferred. The higher the score, the greater the
improvement. Walker and Hill-Polerecky (2011) calculated the test-retest reliability of the
HPLP II as 0.892 after a three-week interval. They also reported the internal consistency as
Cronbach’s alpha 0.943, while the subscales range from 0.793-0.872. Walker and Hill-Polerecky
(2011), performed several validity measures which was confirmed by factor analysis. These
analyses confirmed the six-dimensional structure of HPLP II which was also supported
by convergence with the Personal Lifestyle Questionnaire (r = 0.678) as well as a nonsignificant
correlation with social desirability. The HPLP II has significant criterion validity with concurrent
measures of perceived health status and quality of life (r = 0.269-0.491). A written request for
permission to use this measurement tool was sent to Dr. Sechrist and Dr. Pender and permission
was granted. In addition to the HPLP II questionnaire, other data collected included
demographics on gender, age, current dietary and exercise habits.
Data collection form. During this project, a data collection form was provided to
participants on the first and last day of the psychoeducational session. The form collected
information on gender and age of participants as well as list of antipsychotic medications.
Participants also completed a weekly log which tracked their daily fruit and vegetable intake as
well as minutes of physical activity.

MINIMIZING ANTIPSYCHOTIC SIDE EFFECT

23

Program Evaluation Form. A post-psychoeducational intervention evaluation form was
completed by participants on the last day of the group sessions. Participants evaluated the
psychoeducational sessions and whether they adopted healthy lifestyle changes due to the
knowledge gained from the SIMPLE program.
Implementation
The psychoeducational sessions were advertised with a recruitment flyer positioned at the
check-in window of the outpatient clinic. The project consisted of group psychoeducational
sessions held on Tuesday and Thursday evenings for 30-45 minutes. The Tuesday sessions were
identical to the sessions on Thursday which provided participants flexibility in group attendance.
The sessions were held over a 4-week period and each participant was expected to participate in
four out of the eight sessions offered. During the first session, participants required an extra 30
minutes to sign informed consent and fill out demographic forms. The HPLP II was administered
to participants prior to beginning the first psychoeducation session as well as during the final
psychoeducational session.
During the first week, participants were educated on the benefits of antipsychotic
medications and provided an overview of the metabolic and cardiovascular side effects of this
class of medication. The second week’s psychoeducational group session focused on realistic
dietary changes where participants were taught how to read food labels, meal planning, keep
food journals, understand portion control as well as provided budget friendly food shopping tips.
The third week of the group sessions addressed physical activity and highlighted tips on how to
increase physical activity and have fun. In week four which was the final week of the group
sessions, participants were provided tips on how to control hunger and deal with cravings. Ideas
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on how to identify personal support system was discussed and the weekly sessions were
summarized.

Data Analysis
Data analyses was conducted using IBM SPSS® software version 25. Two tables of
paired t-Tests were computed to compare pre and post test results. Indicators for metabolic and
cardiovascular risk factors, dietary habits, and physical activity level as well as responses to
HPLP II pre and post psychoeducational intervention was measured. Pre and post HPLP II
questionnaire scores was analyzed using paired t-test to determine the level of significance.
Paired t-test for all the six subscales was calculated individually to determine whether any
significant change existed. Using a paired sample t-test, pre and post data on daily consumption
of fruits/vegetables as well as physical activity level was analyzed for significance.
Results
A total of 16 participants completed the pre and post-test assessment. There were 7
females and 9 male participants within the age range of 23 to 60 years of age; with a mean age of
43. (Table 1).
Table 1
Demographic Characteristics of Participants (N = 16)

Characteristic

n

percentage

Male

9

56.2

Female

7

43.8

Age (M)

43
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Health Promotion Lifestyle Profile II (HPLP II)
Participants’ responses on the HPLP II before and after the psychoeducational
intervention were analyzed using paired-t tests. Results of the paired t-test are presented in Table
2 which compared the pre and post intervention assessment of the HPLP II subscales as well as a
paired sample t-test for the overall HPLP II. There was significant increase in pre-test score for
HPLP II (M = 16.675, SD = ± 2.385) compared to post-test score for HPLP II (M = 21.104, SD =
± 2.287). The overall mean difference was 4.729 with a 95% confidence interval (CI) as well as
Cohen’s d of (1.66) which indicated a Large effect size (Table 2).
Table 2
Paired Samples t-test for the Total and Subscales of Health-Promoting Lifestyle Profile II

HPLP II Scale Mean

SD

Mean
SD
difference

t

df

p

Pre-HPLP II
(overall)
Post HPLP II
(overall)

16.675

2.385

4.729

2.841

16.308

95

< .001

21.104

2.287

Pre-Stress
Management
Post-Stress
Management

16.563

1.896

4.125

1.408

11.716

15

<. 001

20.688

1.448

4.5

3.54

5.084

15

< . 001

Pre-Nutrition 16.75
Post-Nutrition 21.25

2.745
2.408
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PreInterpersonal
Relationship
PostInterpersonal
Relationship
Pre-Physical
Activity
Post-Physical
Activity

16.125

2.125

20.375

2.391

16.875

3.612

21.5

3.183

Pre-Health
16.188
Responsibility
Post-Health
21.688
Responsibility

1.721

Pre-Spiritual
Growth
Post-Spiritual
Growth

15.75

1.844

21.125

2.336
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4.25

1.238

13.729

15

< .001

4.625

5.227

3.54

15

.0015

-5.5

1.673

-13.148

15

< . 001

5.375

1.784

12.05

15

< . 001

1.621

Physical activity. The results depict an increase in amount of time engaged in physical
activity among the 16 participants who completed the project. The mean physical activity
minutes for the 16 participants at the start of the project was 48.125 minutes, and the mean at the
end of the project was 67.5 minutes. Paired sample t-test for comparing time spent in physical
activity before and after the intervention was statistically significant p = .0033 (Table 3).
Table 3
Paired Samples t-Test Results for Physical Activity Reported for Project Duration
HPLP Scale

Group
Means

SD

Mean
SD
Difference

t

df

Pre-Physical
Activity

48.125

32.958

19.375

3.148

15

24.622

p

.0033*
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Post-Physical
Activity

67.5

27

23.944

Note. * significant p value.
Fruits and vegetables intake. The project’s results showed that there was as increase in
fruits/vegetables intake among the 16 participants who completed the project. The mean
fruits/vegetable intake for the 16 participants at the start of the project was 1.047 cups, and the
mean at the end of the project was 1.656 cups. Paired sample t-test for comparing
fruits/vegetables intake before and after the intervention was statistically significant p < .001
(Table 4).
Table 4
Paired Samples t-Test Results for Fruits/Vegetables Intake Reported for Project Duration
HPLP Scale

Group
Means

SD

Mean
SD
Difference

t

df

PreFruits/Vegetable 1.047
Intake

0.621

0.609

3.982

15

PostFruits/Vegetable 1.656
Intake

0.612

0.612

p

< .001*

Note. * significant p value.
Program evaluation. A post-psychoeducational intervention evaluation form was
completed by all sixteen participants on the last day of the group sessions. All participants
(100%), reported the sessions provided an overview of the antipsychotic medications and
explained the metabolic and cardiovascular side effects of antipsychotic medication. All the
participants (100%), reported the sessions provided tips on healthy dietary habits and ways on
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how to increase physical activity. All participants (100%), reported the group sessions resulted in
substantial healthy lifestyle changes through diet and exercise.
Discussion
Several RCTs (Bersani, 2017; Curtis, 2016; Erickson, 2017) and clinical research
(Penninx, 2018) support the need to utilize healthy lifestyle changes and life skills through
psychoeducation to mitigate the metabolic side effects of antipsychotic medications. The
literature reviewed in this project highlighted the positive impact psychoeducation which
emphasized increased physical activity as well as healthy dietary choices had on the overall
wellbeing of patients prescribed antipsychotic medications (Bersani et al., 2017). The findings
from this project are consistent with the literature. Participants reported improvement in the
amount of time they were engaged in physical activity as well as increased their intake of
fruits/vegetables over the four-week period of this project. Based on the outcome of this project,
utilizing non-pharmacological interventions such as psychoeducation with an emphasis on
behavioral and lifestyle modification through dietary changes and physical activity can increase
awareness and encourage behavioral changes on ways to manage antipsychotic medication
metabolic side effects.
Limitations
The project sample size (n=16) represented a small fraction of the target patient
population which could have benefited from this project. The four-week timeframe for project
implementation and evaluation was not adequate to assess the long term benefit of the
psychoeducational program to participants. Participants’ personal assessment of fruit/vegetable
intake as well as physical activity level also posed a limitation to the project due to possible
discrepancies in reporting. The community impact of the COVID 19 pandemic caused anxiety
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among participants leading to two participants terminating their involvement in the project at the
end due to underlying medical conditions which affected project sample size.
Implications
Clinical Practice
The EBP project focused on educating participants on practical ways to minimize
antipsychotic medication side effect through psychoeducation. The intervention was successful
in improving patient outcomes as evidenced by the post-intervention data and is aligned with the
overwhelming support for psychoeducational intervention in already existing literature (Bersani
et al., 2017; Curtis et al., 2016; Erickson et al., 2017). This four-week project although brief in
time frame, suggested benefits for a longer duration of a similar project. The DNP-prepared
nurse could thus play a leading role in identifying, implementing and sustaining facility wide
changes which would improve the overall wellbeing among the vulnerable mentally ill patient
population.
Policy
At the local, state and national levels, advocacy for legislations and programs which
would improve health literacy through patient education especially among patient diagnosed
with mental illness needs to be to be considered. Programs focused on psychoeducation
explaining the need for treatment compliance and ways to minimize medication side effects
among vulnerable populations could bridge the health disparity gap among patients diagnosed
with mental illness. According to the American Association of Colleges of Nursing (AACN),
one role of the DNP-prepared advance practice nurse is to become an innovative leader in the
transformation of the current health care system (AACN, 2004). The DNP prepared nurse must
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be prepared and ready to lead, collaborate and advocate with the goal of improving patient and
healthcare outcomes.
Quality and Safety
A primary diagnosis of mental illness such as Major Depression, Bipolar Disorder, and
Schizophrenia could contribute to an increased risk of premature death resulting in 2-3 times
higher mortality rate among this vulnerable population (Pringsheim et al., 2017). According to
the literature, cardiovascular conditions account for a portion of this elevated mortality rate
(Curtis et al., 2016; Erickson et al., 2017) but the good news is that there are modifiable risk
factors which could be used to mitigate these metabolic and cardiovascular conditions. Among
the general population, management of cardiovascular conditions are challenging but it is
significantly problematic among patients diagnosed with severe mental conditions.
In addition to psychoeducation on health lifestyle changes, healthcare providers are
encouraged to routinely monitor patients at risk for metabolic and cardiovascular side effects
originating from prescribed antipsychotic medications (Pringsheim et al., 2017). Adhering to
evidence-based guidelines on appropriate screening protocol and antipsychotic safety monitoring
would not only decrease antipsychotic medication side effects but eventually save lives
((Pringsheim et al., 2017).
Education
Implementation of EBP leads to quality care and best outcomes, reduces cost and
disparity, empowers clinicians and increases role satisfaction (Melnyk & Fineout-Overholt,
2015). Continuity of seeking and implementing current best evidence is imperative to prevent
outdated treatment that will lead to poor patient outcomes. The DNP-prepared nurse must
continue to implement practice change projects, educate patients and caregivers, advocate policy
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changes that sustains EBP change and embrace new evidence to combat non-adherence. It will
be beneficial for future work to recognize the role of families/caregivers. Providing
psychoeducation to the entire family/caregivers on the need to include healthy lifestyle changes
in the lives of patients prescribed antipsychotic medications will be more effective than an
individual session.

Sustainability
Long term strategies are needed in order to sustain a project change. Upon completion of
this EBP change project, the PI and stakeholders at the implementation site are considering a
number of approaches to sustain the positive changes that were achieved. These approaches
include the addition of psychoeducational groups to treatment as usual for patients prescribed
antipsychotic medications. Psychiatrists, APRNs, and Physician Assistants (PA) at the clinical
site will recommend psychoeducational sessions to patients/caregivers, and front office staff
have been assigned to compile names for the Licensed Clinical Social Workers (LCSW) who
will develop group sessions involving prescribers as well. Participants who took part in the
recently completed EBP change project will be given the opportunity to participate, with the goal
of reinforcing what was previously learned.
Future Scholarship
Collaboration among a wide range of mental health providers is planned to engage a
larger number of participants and to implement future projects in a larger area of the community.
Poster presentations at professional organizations comprising mental health providers such as
American Psychiatric Nurses Association (APNA) Nevada chapter will be utilized to accomplish
this goal. Psychoeducational intervention must be added to treatment as usual for patients
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prescribed antipsychotic medications. Patients are more likely to adhere to their treatment
regimen if they have a better understanding of how to mitigate and manage unwanted medication
side effects.
Conclusion
The consequences of antipsychotic induced medication cardiovascular and metabolic side
effects are dire. Utilizing psychoeducation during treatment as usual can be an effective
intervention in improving adherence to medications regimen as well as decreasing these
unwanted medication side effects. Psychoeducational interventions are designed to impart
knowledge on antipsychotic medication metabolic side effects and its management through
lifestyle changes. The pre-test and post-test data analysis among participants before and after the
project intervention reinforce that psychoeducation positively impacts lifestyle changes among
patients prescribed antipsychotic medications. Implementing the tenets of this project at the
practice site as well as other behavioral health sites could manage the metabolic and
cardiovascular side effects from antipsychotic medications and eventually improve overall
wellbeing for patients diagnosed with mental illness.
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